The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2018

Filed:

Apr. 06, 2016
Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Soldano Ferrone, Boston, MA (US);

Xinhui Wang, Boston, MA (US);

Thomas P. Conrads, Reston, VA (US);

Elvira Favoino, Bari, IT;

Brian L. Hood, Reston, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/13 (2006.01); C12N 15/62 (2006.01); C12N 15/70 (2006.01); C12N 15/79 (2006.01); C12N 5/10 (2006.01); C12N 1/21 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01); C12N 15/86 (2006.01); C12N 15/82 (2006.01); C12N 15/09 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 47/6843 (2017.08); C07K 16/30 (2013.01); C07K 16/303 (2013.01); C07K 16/3015 (2013.01); C07K 16/3023 (2013.01); C07K 16/3038 (2013.01); C07K 16/3053 (2013.01); C07K 16/3069 (2013.01); C07K 16/3092 (2013.01); G01N 33/574 (2013.01); G01N 33/577 (2013.01); A61K 39/00 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/622 (2013.01); C07K 2317/624 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C12N 5/10 (2013.01); C12N 15/09 (2013.01); C12N 15/62 (2013.01); C12N 15/8258 (2013.01); C12N 15/86 (2013.01); C12N 2800/00 (2013.01); C12N 2810/859 (2013.01); G01N 2333/47 (2013.01); G01N 2333/4727 (2013.01); G01N 2800/7028 (2013.01);
Abstract

Isolated monoclonal antibodies are disclosed herein that specifically bind endoplasmin. In some embodiments these antibodies are fully human. Recombinant nucleic acids encoding these antibodies, expression vectors including these nucleic acids, and host cells transformed with these expression vectors are also disclosed herein. In several embodiments the disclosed antibodies are of use for detecting and/or treating tumors that express endoplasmin, such as melanoma, breast cancer, head and neck squamous cell carcinoma, renal cancer, lung cancer, glioma, bladder cancer, ovarian cancer or pancreatic cancer. In one example, the tumor is a melanoma.


Find Patent Forward Citations

Loading…